Videos / Vaginal micronised progesterone soft gel capsule for the treatment of threatened miscarriage
In this Product Explainer, Professor of Obstetrics & Gynaecology, William Ledger explains the role of vaginal micronised progesterone, including the indication, safety profile, clinical trial background and guidelines for use for the treatment and management of threatened miscarriage (5 mins).
Tirzepatide Compared to Semaglutide for Treatment of Obesity – Latest Evidence
Genitourinary Syndrome of Menopause – Mythbusting for GPs
Dysmenorrhoea in Teens
Winter Virus Preparations
expert
Fertility Specialist; City Fertility Sydney, Emeritus Professor of Obstetrics and Gynaecology; School of Medicine, University of New South Wales